Ruminant and swine pestiviruses are among the most insidious and devastating viral pathogens of farm animals worldwide (4, 27) . Bovine viral diarrhea virus (BVDV) is the prototype species in the Pestivirus genus of the Flaviviridae. Although this virus family is best known for its arthropodborne agents such as yellow fever and dengue virus, it also comprises blood-borne agents such as hepatitis-associated viruses, e.g., hepatitis C virus (HCV), in a separate genus (22) . Hepatitis C and hepatitis G viruses are more closely related to pestiviruses than to arthropod-borne flaviviruses by several criteria. However, each group has certain unique biological features which make general extrapolations difficult (9, 29, 40, 42) . Notwithstanding the many important differences between HCV and pestiviruses, the use of BVDV and related pestiviruses as models to study aspects of non-arthropod-borne flavivirus replication and interaction with cells may contribute to their understanding. Development of antiviral drugs to treat hepatitis C patients has lagged because HCV has never been cultured efficiently in vitro and chimpanzees are the only animal model for the virus.
BVDV remains enzootic in cattle populations throughout the world. Current BVDV vaccines are relatively unsafe when used to vaccinate pregnant or persistently infected animals and sometimes of limited value in control and eradication programs (20, 51) . Efficient reverse-genetics approaches using a molecular clone of the BVDV genome may contribute to the development of rationally designed safe and efficacious vaccines.
The construction of infectious molecular clones of arthropod-borne flaviviruses such as yellow fever, dengue, and Japanese encephalitis viruses has been instrumental in the elucidation of viral replication mechanisms and molecular determinants of virulence (5-7, 15, 33, 35, 43, 46) . Development of reverse-genetic systems for swine pestivirus strains has been reported by three different groups very recently (39, 41, 54) . It is anticipated that addition of the related bovine pestivirus to the set of non-arbo flaviviruses whose genomes can be manipulated will aid in the understanding their molecular biology and pathogenesis.
We report the construction of an infectious molecular clone of BVDV, its subsequent modification to introduce a sequence tagged site, and the production of a chimeric virus expressing a surface glycoprotein from a different BVDV strain. With these data we demonstrate the feasibility of manipulating the BVDV genome in vitro and the potential effectiveness of this cDNA clone for reverse-genetic analyses of pestiviruses.
MATERIALS AND METHODS
Cells, viruses, vectors, and hosts. Embryonic bovine trachea (EBTr) cells and the National Animal Disease Laboratory (NADL) strain of BVDV were from the American Type Culture Collection (CCL-44 and VR-534, respectively). This strain of BVDV was isolated from the spleen of a naturally occurring fatal case of BVDV infection (25) . Bovine testicle (BT) cells were prepared as described previously (18) . BVDV strain Singer is a cytopathic virus provided by Edward Dubovi (34) . Vaccinia MVA-T7 was provided by B. Moss (56) . Escherichia coli JM109 was from Promega and GM119 (F Ϫ supE44 lacY1 galK2 galT22 metB1 dam-3 dcm-6 tsx-78 Ϫ ) was kindly provided by R. Barletta (1) . Monoclonal antibodies (MAbs) were described previously (12) . Five cDNA plasmid clones with overlapping fragments of the BVDV strain NADL genome were described previously (10, 11) . Synthetic oligonucleotides were used to restore segments of the 5Ј and 3Ј ends of the BVDV genome (13) .
Construction of a BVDV cDNA clone and derivatives. A set of plasmids bearing overlapping cDNAs from the BVDV genome was used to assemble a full-length copy of the viral genome in a single plasmid DNA molecule following standard procedures (2, 10, 11, 32) . The assembly process comprised numerous intermediate cloning steps to join the original cDNA clones, restore the 5Ј and 3Ј termini of the viral genome, and correct altered BVDV genomic sequence as well as tailor signals for runoff RNA transcription in vitro. The 5Ј and 3Ј end sequences were as described previously (13) . Details of these cloning steps are available upon request from the authors. The resulting plasmid, termed pVVNADL, consists of the full-length cDNA of the BVDV genome flanked by an upstream T7 promoter which directs transcription start at BVDV nucleotide position 1. A SacII endonuclease recognition sequence was tailored at the 3Ј end of the BVDV 3Ј untranslated region (UTR) to allow template linearization for the production of positive-sense RNA molecules of 12,578 nucleotides by runoff transcription with T7 RNA polymerase. Introduction of a sequence tag into the BVDV genome was performed by digesting pVVNADL with DraIII and treating linear DNA with T4 DNA polymerase to remove the 3Ј overhang. The blunted DNA was recircularized with T4 DNA ligase, and the resulting pVVNADL⌬Dra plasmid was sequenced to verify the three-nucleotide deletion.
To substitute a region of the BVDV NADL genome encoding the major envelope glycoprotein E2/gp53, transfer vector pVVNADL⌬SA was constructed by deletion of a SalI-AatII fragment from pVVNADL, comprising all the nonstructural protein-encoding region downstream of the SalI site (nucleotides 5621 to 12542). A PvuII-XcmI fragment of pVVNADL⌬SA encoding E2/gp53 was replaced by using standard methods with a homologous cDNA fragment derived from the Singer strain of BVDV by reverse transcription (RT)-PCR. The resulting pVVNADL⌬SA-SINgp was digested with ClaI and DraIII to isolate a fragment representing the 5Ј 5,184 nucleotides of the BVDV genome to be ligated to pSD-MLU3Ј digested with ClaI and DraIII to create the appropriate window. The resulting construct was termed pVVNADLSINgp and has Singer strainderived genomic sequences from nucleotide position 2199 to 3497 replacing the original BVDV strain NADL sequences.
In vitro transcription and RNA transfections. RNA transcripts were synthesized in vitro with T7 RNA polymerase, under conditions adapted from previously published methods (3, 26, 55) , from a template consisting of the full-length cDNA of the BVDV genome contained in pVVNADL linearized with SacII and treated with T4 to remove the 3Ј overhang. Capped RNA was synthesized with a T7 RNA polymerase in vitro transcription kit (Ambion, part 1344). Transcription reaction products were analyzed by gel electrophoresis and Northern analysis, using a probe derived from the 5Ј end of the BVDV genome (2) . RNA synthesized in vitro was digested with RNase-free DNase I, precipitated with isopropanol, washed in ethanol, and used to transfect EBTr cells by electroporation as described below. Controls included electroporation of a transcription mix lacking template DNA, or T7 RNA polymerase, or the use of a truncated subgenomic cDNA template. Electroporated cells were distributed into dishes containing glass coverslips to allow acetone fixation and immunostaining for fluorescence microscopy (17) .
Integrity of the open reading frame was assessed on BT cells infected with vaccinia virus MVA-T7 by transient gene expression as described previously (56) . Cells were fixed and probed for expression of E2/gp53 or NS2-3/p125 with specific MAbs (12) . RNA transfection was essentially as described by Liljestrom, with modifications to optimize for EBTr cells (28) . Briefly, 3 ϫ 10 6 EBTr cells resuspended in medium containing 3 g of isopropanol-precipitated RNA were electroporated by two consecutive discharges of 1,700 V/cm and 25 F in a 0.4-cm cuvette with a Gene Pulser instrument (Bio-Rad). RNA transfer efficiency was assessed by removing coverslips at 24 and 48 h after plating and processing for immunofluorescence by using a MAb to BVDV. Production of infectious progeny virus was assessed by harvesting culture medium from transfected monolayers, filtering through 0.45-m-pore-size membranes, and inoculation onto BT cells. Infection of BT cells was monitored by development of cytopathology and immunostaining with specific MAbs.
Phenotype and genotype analyses. Phenotype analyses of all plasmid-derived viruses were carried out on stocks prepared after three cell culture passages on BT cells. Analyses included kinetics of infectious virus release following RNA transfection, plaque morphology, and growth kinetics at three incubation temperatures-35, 37, and 39.5ЊC-by standard protocols (17) (18) (19) . Antigenic analyses included seroneutralization assays and immunofluorescence probing by using a panel of nine MAbs which recognize E2/gp53 polymorphisms or conserved E0/gp48 epitopes, as described previously (12) . To prepare RNA for viral genotype analyses, BT cells were infected with BVDV at an input multiplicity of 5 and the monolayers were lysed at 18 h after infection for RNA extraction as previously described (21) . RT-PCR was performed with appropriate synthetic oligodeoxynucleotide primer pairs as described (2, 44, 49, 52) . DNA amplified with Taq DNA polymerase was sequenced as described previously (57) .
RESULTS

RNA transcribed in vitro yields infectious BVDV.
Initial efforts led to the construction of two plasmids, each carrying cDNA representing approximately the 5Ј and 3Ј halves of the BVDV genome. pBV18-F2 consists of a T7 RNA polymerase promoter abutted to the viral 5Ј UTR and adjacent polyprotein open reading frame sequences encoding the viral structural proteins. The second plasmid (pSD-MLU3Ј) encompasses the nonstructural protein region and the 3Ј UTR of the BVDV genome followed by a SacII restriction endonuclease site (Fig.  1 ). These plasmids were used to join the two halves of the viral genome to give rise to a genomic-length construct termed pVVNADL (Fig. 1) .
The plasmid carrying the entire genome of BVDV, pVVNADL, contains the ColE1 replicon derived from pGEM4 and is 14,578 bp in length. The plating efficiency of E. coli (strain GM119 or JM109) hosts transfected with supercoiled pVVNADL DNA on ampicillin-containing solid medium is 100-fold lower than that of cells receiving pGEM4 DNA. E. coli GM119 proved to be a more suitable host for pVVNADL than strain JM109, which led to frequent DNA deletions (data not shown).
The integrity and continuity of the polyprotein open reading frame was assessed by T7-driven transient expression of transfected pBV18-F2 DNA. Cells previously infected with vaccinia virus MVA-T7 expressing T7 RNA polymerase and transfected with pBV18-F2 DNA showed bright immunofluorescence with MAbs to structural viral proteins indicating expression of genuine viral proteins from an uninterrupted polyprotein open reading frame (data not shown).
Runoff RNA transcripts synthesized in vitro with phage T7 RNA polymerase from SacII-linearized pVVNADL were largely subgenomic in size with only a minor proportion of BVDV genome-length RNA molecules (Fig. 2) . Transfection of this unselected heterogeneous population of transcripts into EBTr cells by electroporation resulted in typical BVDV cytopathology, i.e., vacuolation and detachment of the monolayer from the culture dish, after 72 h (23). In contrast, EBTr cells transfected with truncated subgenomic transcripts and processed in the same fashion did not show these changes. In cells transfected with pVVNADL transcripts, expression of structural and nonstructural BVDV proteins was observed in 1 to 3% of the EBTr cell population as early as 24 h after transfection by immunofluorescence with BVDV-specific MAbs. The proportion of positive cells rose to 10 to 20% by 48 h following transfection. Cell culture fluids were harvested periodically and used to determine the kinetics of infectious virus release (Fig. 3) and for subsequent propagation of the rescued infectious virus on BT cells. Release of infectious virus was detected as early as 36 h posttransfection (Fig. 3) . Culture supernatants from EBTr cells transfected with pVVNADLtemplated transcripts caused cytopathic changes in BT cells 48 h after inoculation, while cell culture medium from control EBTr monolayers transfected with truncated transcripts had no effect.
The antigenic phenotype of the virus rescued from pVVNADL transcripts, termed i-VVNADL, was indistinguishable from that of the parental NADL virus as assessed by immunofluorescence staining with a panel of MAbs against the E2/gp53 and E0/gp48 envelope glycoproteins (Table 1 ). Growth properties of the i-VVNADL at different temperatures were similar to those of parental BVDV NADL virus by plaque morphology (data not shown) and kinetics of progeny yield determined at 35, 37, and 39.5ЊC (Fig. 4 , panels A to C, respectively). Progeny yields from i-VVNADL-infected cells tended to be modestly higher than the parental NADL BVDV yields at the three temperatures, with a significant difference at 39.5ЊC.
BVDV with a sequence-tagged genome has wild-type phenotype. While the above results suggest that RNA transcripts derived from pVVNADL are infectious, the experiments do not formally exclude the possibility that transfected cultures somehow became contaminated with parental whole virus. Although this was an unlikely explanation of our results, we constructed a modified pVVNADL to allow unambiguous identification of viruses rescued from plasmid-derived RNA transcripts. To this end, we introduced a sequence tag into the BVDV genome. The ideal tag should be a unique sequence, readily identifiable by restriction fragment length polymorphism analysis, and should be neutral with respect to the viral phenotype. A deletion which results in loss of a DraIII restriction enzyme recognition site at nucleotide 5179 of the BVDV genome and gain of a PmlI site was introduced in the pVVNADL construct. We chose this location because the region of the BVDV genome between nucleotides 4993 and 5263 consists of an insertion of bovine mRNA sequence in the NADL strain and may thus tolerate a deletion (38) .
Infectious virus was indeed rescued from pVVNAL⌬Dra-templated transcripts with the same kinetics as with the intact wild-type (WT) full-length cDNA clone; e.g., transfected cells showed a large proportion of infected cells by immunofluorescence of coverslips fixed at 48 h (data not shown). Characteristic vacuolating cytopathology could be observed in transfected cells by 72 h after transfection and in subsequent passages of the culture medium onto new BT cells. Restriction enzyme analysis of a 183-bp amplicon spanning the DraIII site amplified by RT-PCR from i-VVNADL⌬Dra (Fig. 5) revealed the presence of PmlI site CACGTG and the absence of DraIII site CACagaGTG. In contrast, DNA amplified from parental virus showed the reciprocal susceptibility to cleavage with these enzymes, characteristic of the NADL strain of BVDV (Fig. 5) . Antigenic analysis reveals that the i-VVNADL⌬Dra virus is essentially identical to the parental NADL virus as ascertained by MAb analyses (data not shown). Growth properties of i-VVNADL⌬Dra analyzed in vitro were similar to those of WT parental virus, although curves are shifted upward due to increased yields from i-VVNADL⌬Dra (Fig. 4 , panels D to F). Thus, the single amino acid deletion from the vicinity of the putative cleavage site within p125/NS23 did not com- 
promise the fitness of i-VVNADL⌬Dra or substantially alter its phenotype in vitro. BVDV chimera displays hybrid phenotype. Construction of viral genomic RNA chimeras is a powerful approach to identify genomic sequences responsible for particular phenotypic characteristics. As a model to demonstrate their feasibility with the full-length BVDV NADL cDNA clone as a recipient, antigenic chimeras were constructed by replacement of a genome segment with a homologous fragment derived from the Singer strain of BVDV. Unique genetic and antigenic markers are present exclusively in each of the two parental strains and were used to identify the newly created chimeric virus. First, a unique 270-base stretch of sequence derived from the cattle genome at position 4993 is a characteristic marker of the NADL strain of BVDV (36, 37) . Another marker is constituted by unique amino acid sequences of the E2/gp53 envelope glycoprotein which confer the Singer strain reactivity with MAbs 10, 31, 32, and 39 by immunoassay and neutralization. Thus, the donor Singer strain does not have the 270-nucleotide insert, while the recipient NADL strain encodes a E2/gp53 which fails to bind a subset of four MAbs (12, 45) . By replacing the original envelope glycoprotein in the WT pVVNADL cDNA clone with sequences coding for the Singer envelope gene, we predicted a chimeric virus which will carry the epitopes present in the Singer strain envelope E2/gp53 and the 270-nucleotide bovine insert at position 4993. We substituted the pVVNADL PvuII-XcmI fragment (nucleotide position 2199 to 3497) which encodes for the C terminus of E1/gp25 and the entire ectodomain of E2/gp53 with homologous sequences from the Singer strain of BVDV. Infectious chimeric virus was recovered from transcripts derived from pVVNADLSINgp. Nucleotide sequence analyses of the i-VVNADLSINgp chimeric virus genomic RNA across the substituted fragment and the flanking regions reveals the chimeric structure of the genome (Fig. 6) . Furthermore, the 270-nucleotide bovine sequence insert at nucleotide 4993 characteristic of the NADL strain is present in i-VVNADLSINgp chimeric virus genomic RNA, as indicated by the size of the amplicon obtained by RT-PCR (data not shown). Plaque morphology and growth kinetics of the chimeric virus, termed i-VVNADLSINgp, revealed that its growth properties are very similar to its parental NADL strain virus (Fig. 4 and data not shown) . In contrast, the antigenic properties of the chimeric virus depart from those of the BVDV strain NADL ancestor (Tables 1 and 2 ). The pattern of reactivity of proteins encoded by the chimeric i-VVNADLS INgp with a panel of E2/gp53-specific MAbs reveals that this virus expresses an E2/gp53 with an antigenic profile identical to that of the Singer isolate, by immunofluorescence (Table 1) . Interestingly, subtle differences were observed between the latter two viruses (i-VVNADLSINgp and Singer BVDV) in neutralization titers with MAbs 10 and 39, but the overall patterns are conserved (Table 2 ). In contrast, the virus recovered from the parental pVVNADL cDNA (i-VVNADL) has an E2/gp53 indistinguishable from that of the NADL strain (Tables 1 and 2 ). Taken together, the experimental evidence indicates that i-VVNADLSINgp represents a chimeric virus consisting of a genomic backbone from the NADL strain of BVDV but expressing the Singer strain E2/gp53 glycoprotein as well as the C-terminal end of E1/gp25.
DISCUSSION
Three separate experimental lines of evidence led us to conclude that we have established a system to generate infectious BVDV from RNA transcripts synthesized in vitro. First, transcripts derived from pVVNADL yield infectious BVDV only when generated from full-length templates linearized with SacII endonuclease; subgenomic transcripts failed to yield virus following transfection. Second, introduction of a genomic tag in pVVNADL results in rescue of a virus with the predicted genomic tag. Third, replacement of the E2/gp53-encoding region in pVVNADL with that of the Singer strain led to production of a chimeric virus with the expected changes on its surface glycoprotein.
Having successfully established an experimental system to produce infectious transcripts and rescue BVDV by transfecting uncapped RNA transcripts produced by T7 RNA polymerase allows three additional concepts to be addressed. The first concerns the structure of the 5Ј end of the viral RNA. RNA without a 5Ј cap structure was infectious, suggesting that a cap-independent translation initiation mechanism is used by BVDV genomic RNA for gene expression. This result is compatible with biochemical evidence suggesting that the 5Ј end of genomic RNA was not blocked by inverted methylguanosine (13) . Transfection of RNA transcribed in vitro from pVVNADL DNA template in the presence of the cap analog gave rise to infectious virus as well, but with delayed kinetics (data not shown). Inefficient full-length RNA transcript production due to high capped-to-uncapped GTP ratios may have contributed to the delayed recovery of infectious virus following capped RNA transfection. Lacking a homogeneous population of capped RNA, we were unable to establish whether infection virus production resulted from capped RNA or from residual uncapped RNA. Although we cannot exclude the possibility that capped BVDV transcripts are infectious, we can conclude that 5Ј capping is certainly dispensable for BVDV RNA infectivity and does not seem to enhance it.
The second concept emerges as a corollary of the first. An internal ribosome entry site element in the 5Ј UTR of the BVDV genome identified as such in reticulocyte lysates must be functional to direct cap-independent translation of the genome and virus replication (48) . The third concept relates to the 5Ј and 3Ј termini of the viral RNA, thought to contain plusand minus-strand RNA replicase promoter elements, respectively. Technical difficulties are commonly encountered in approaches to determine the nucleotide sequence of 5Ј and 3Ј termini of large viral RNA molecules. However, the sequences reported by Deng and Brock (13) and incorporated in pVVNADL gave rise to infectious virus with the WT phenotype, indicating for the first time their functionality (13) .
To the best of our knowledge the 12,578-base genome of BVDV constitutes the largest positive-strand viral cDNA clone which yields infectious RNA transcripts. Moreover, the cDNA clone is replicated as a single plasmid in E. coli. However, the plating efficiency of E. coli hosts such as strain JM109, transformed with pVVNADL and its derivatives and plated on ampicillin-selective medium, was reduced by 2 to 3 orders of magnitude as compared to the pGEM4 vector alone. This problem was compounded by the high frequency of DNA deletion in transformant cells, despite the Rec Ϫ phenotype of the strain JM109 E. coli host. Instability of large cDNA clones is not uncommon and often determines utilization of alternative strategies involving generation of transcription DNA templates in vitro by ligation or long PCR (24, 50) . However, we found that certain strains of E. coli, e.g., GM119, circumvented such difficulties. The basis or other biochemical correlates of the greater stability of pVVNADL in this host are unknown.
The specific infectivity of the RNA transcripts could not be determined with reasonable accuracy because full-length runoff transcripts were produced in vitro with low efficiency by T7 RNA polymerase, apparently due to the intrinsic properties of the 12.5-kb pVVNADL template. The SacII endonuclease used to linearize the template cleaves DNA to produce a 3Ј overhang. The possibility that incomplete T4-DNA polymerase removal of the 3Ј overhang could negatively affect transcription was excluded since template linearized by XbaI or MluI enzymes, which cleave generating 5Ј overhangs downstream of the SacII site, revealed similar patterns of premature transcription termination, without improvement in full-length RNA transcription (data not shown). In contrast, pVVNADL DNA linearized at position 2828 (RsrII) or position 5621 (SalI) of the BVDV genome gave rise to high yields of discrete-sized RNA by runoff transcription with virtually no heterogeneous abortive products (Fig. 2, lanes 1 and 2) . Although the T7 RNA polymerase is highly processive for elongation of shorter transcripts, certain secondary structures in nascent transcripts can act as termination signals (31) . The probability of such fortuitous events increases with transcript length. The presence of discrete subgenomic length RNA molecules was observed in electrophoregrams of transcription reaction products. Low yields of full-length transcripts are not uncommon and also occur in other pestivirus cDNAs as shown for classical swine fever virus in two of three independent reports (39, 41) . Unfractionated transcription products yielded infectious virus within 36 h posttransfection. Ruggli et al. reported 22 to 26% full-length transcripts with a classical swine fever virus cDNA of 12.3 kb under similar reaction conditions (54) . The specific infectivity of this in vitro-synthesized classical swine fever virus RNA was 5 ϫ 10 4 /mg of full-length RNA. Direct comparison of the specific infectivity of this classical swine fever RNA transcripts with the BVDV RNA from our laboratory awaits synthesis of enriched full-length transcripts. In other reports, the specific infectivity of classical swine fever virus RNA produced in vitro was not measured, but results showed extended eclipse periods (Ͼ72 to 96 h) before infectious virus was recovered from transfected monolayers (39, 41) .
Interestingly, shuttling of the large BVDV RNA genome through cDNA in a prokaryotic plasmid did not result in changes of the viral phenotype in vitro. The phenotype of the virus rescued from the pVVNADL as defined by the parameters and characteristics we studied did not depart significantly from those of the parental BVDV strain NADL. The observed moderately enhanced progeny virus yields from unmodified, tagged, and chimeric BVDV rescued from the in vitro-transcribed RNA as compared to the parental NADL (Fig. 4) could be explained by population quasispecies fitness differences between stocks of the NADL strain of BVDV (16) . Animal inoculation studies will be required to determine how the in vivo phenotype of i-VVNADL and its derivatives compare to WT virus. In two reports, recovery of classical swine fever virus from transfected cells was delayed or required several passages in vitro to regain replication fitness comparable to that of WT virus (39, 41) .
To avoid reversion due to the high plasticity that characterizes RNA genomes, we sought to design a neutral genomic tag that consists of more than a single nucleotide change. A dele- FIG. 6 . Schematic representation of a nucleotide sequence alignment of the region of the BVDV genome between nucleotide 2040 and 3600 from three different viruses: BVDV strain NADL (top), chimeric BVDV strain i-VVNADLSINgp (center), and BVDV strain Singer (bottom). RT-PCR amplicons were sequenced as described in Materials and Methods, and the results of the alignment were displayed by using the GAPSHOW program of the University of Wisconsin Genetics Computer Group Package, depicting differences as vertical bars (14) . The locations of restriction enzyme cleavage sites used to substitute the glycoprotein coding region are indicated. A diagram of the BVDV NADL genomic RNA and the encoded polyprotein is shown at the top. tion of three nucleotides (5182 to 5184: codon 1600) was introduced within the 270-nucleotide insert present in the NS23 coding region of the genome (36, 37) . Presence of this bovine sequence element at nucleotide 4993 is correlated with proteolytic processing of NS2-3, and the latter coincides with viral cytopathogenicity in vitro and virulence in the context of persistently infected animals (19, 36, 37) . Infection of BT cells with the tagged i-VVNADL⌬Dra virus resulted in infection and cytopathology with features and kinetics comparable to those of the parental strain, leading us to conclude that glutamic acid at position 1600 in the NADL strain polyprotein is not important for viral cytopathogenicity. However, this deletion resulted in a convenient restriction fragment length polymorphism tag providing a convenient means to discriminate between WT and tagged genomes. Although we have not examined the virulence of this virus in cattle, its in vitro properties are like those of the WT; thus i-VVNADL⌬Dra constitutes a good candidate virus with a neutral genomic tag to further examine BVDV pathogenicity in cattle. The i-VVNADLSINgp glycoprotein chimera of BVDV displays a unique antigenic phenotype without alterations in replication properties in vitro. This virus can simply be traced by using two markers: the unique epitopes present in E2/gp53 of the Singer strain of BVDV detected with specific MAbs (e.g., 10f9) and the presence of a unique 270-bp bovine sequence insert after nucleotide 4993, detected by PCR, characteristic of the NADL parent and absent in the Singer genome (12, 37, 38) (Tables 1 and 2 ).
Neutralization of virus infectivity by MAbs results from a high-affinity interaction between glycoprotein and antibody (K a values between 10 8 and 10 10 liters mol Ϫ1 ) (53) . Even minor conformational changes in the viral glycoprotein can lower the affinity of the interaction (10 6 to 10 7 liters mol Ϫ1 ) and impair neutralization without preventing binding in immunoassays (44) . MAbs 10 and 39 neutralized the chimeric virus to a lesser extent than did the WT BVDV Singer, suggesting extramolecular influences on the interaction between the MAb immunoglobulin G and E2/gp53. However, MAbs 10 and 39 retained ability to bind the chimeric virus E2/gp53 in immunofluorescence assays, in accordance with the well-established lower stringency of this assay.
We demonstrate that reverse-genetic approaches can be used to introduce specific alterations or tags into the BVDV genome, as exemplified by the deletion of codon position 1600 (glutamic acid). Moreover, construction of chimeric viruses is also feasible, as evidenced by the expression of an envelope glycoprotein from a different BVDV strain. Thus the two main approaches to explore gene function in positive-strand RNA viruses can now be implemented using infectious cDNA clones of BVDV. Although the upper size limits of viable BVDV genomes is unknown, at least 2 kb of additional coding sequences can be part of viable viruses (38) . Consequently, it may be possible to use BVDV as a vector to express foreign proteins for immunization purposes.
Three different groups reported very recently on the development of reverse-genetic systems for classical swine fever virus strains (39, 41, 54) . It will be of interest to determine whether interspecies chimeras of swine and bovine pestiviruses with hepatitis C or G viruses are viable. Precedents exist in retroviruses, picornaviruses, and flaviviruses, supporting the notion that different viral functional units can be substituted with those of viruses of variable relatedness (6, 8, 47) . Notably, the hepatitis C internal ribosome entry site element is functional in poliovirus-hepatitis C chimeras (30) . These chimeric approaches could lead to understanding of in vitro host range in pestiviruses and hepatitis C viruses. Finally, infectious transcripts from cDNA clones could be used to engineer attenuating mutations leading to development of novel live BVDV vaccines.
